413 related articles for article (PubMed ID: 9624579)
1. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
3. IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses.
Fania L; Caldarola G; Müller R; Brandt O; Pellicano R; Feliciani C; Hertl M
Clin Immunol; 2012 Jun; 143(3):236-45. PubMed ID: 22534318
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
5. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
[TBL] [Abstract][Full Text] [Related]
6. Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
Emtenani S; Linnemann BE; Recke A; von Georg A; Goletz S; Schmidt E; van Beek N
J Dermatol Sci; 2024 May; 114(2):64-70. PubMed ID: 38582700
[TBL] [Abstract][Full Text] [Related]
7. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
8. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid.
Delaporte E; Dubost-Brama A; Ghohestani R; Nicolas JF; Neyrinck JL; Bergoend H; Janin A; Capron M
J Immunol; 1996 Oct; 157(8):3642-7. PubMed ID: 8871665
[TBL] [Abstract][Full Text] [Related]
9. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
10. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
[TBL] [Abstract][Full Text] [Related]
11. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
[TBL] [Abstract][Full Text] [Related]
12. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
[TBL] [Abstract][Full Text] [Related]
14. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
15. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
[TBL] [Abstract][Full Text] [Related]
17. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
[TBL] [Abstract][Full Text] [Related]
18. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
